#LegendNews: As we continue our pursuit to transform patients’ lives, we are pleased to announce a positive interim analysis from our Phase 3 #MultipleMyeloma study. Read the topline results: https://bit.ly/4cNaxHt #CellTherapy
Legend Biotech’s Post
More Relevant Posts
-
As a token of appreciation to our LEGENDary team, we had a visit from an ice cream truck at our global headquarters in Somerset, NJ. It was the perfect way to cool down and catch up with colleagues on this hot summer day. #WeAreLegend
To view or add a comment, sign in
-
-
#LegendNews: Legend Biotech will host a webcast to share 2024 second-quarter financial results on August 9. Register to join the live webcast here: https://lnkd.in/g8gFDUqv #CellTherapy
To view or add a comment, sign in
-
-
Our LEGENDs in Ghent, Belgium, embody the phrase “one Legend” and often observe special occasions as a team. Recently, they celebrated the summer solstice together. Team building is a favorite pastime at Legend. Would you like to join our growing team? Click here to see our current openings. https://lnkd.in/e-rXFgQq #WeAreLegend
To view or add a comment, sign in
-
-
Explore our state-of-the-art CAR-T Cell processing facility at Tech Lane in Ghent, Belgium. As the demand for our #CellTherapy increases, we are scaling up our capabilities and streamlining our manufacturing processes to expand capacity and meet patients’ needs. Learn more about our approach: https://lnkd.in/eNs5VmNJ #Biotech #CART
To view or add a comment, sign in
-
In an interview with Pharmaceutical Executive, our CEO, Ying Huang, discusses the promising potential of CAR-T therapies as they move up the #MultipleMyeloma treatment paradigm. Click here to read the article and learn more about our latest data presented at #ASCO24: https://lnkd.in/eer3kCSx
To view or add a comment, sign in
-
Legend Biotech was featured in Scientific American, where we discussed the success of CAR-T cell therapies in transforming the treatment paradigm for #MultipleMyeloma. Learn how we are racing to treat more patients faster: https://lnkd.in/eC_iEmMc #CellTherapy #CART
CAR-T Cells Approach Cancer’s Front Lines
scientificamerican.com
To view or add a comment, sign in
-
We are excited to share the latest data from our #MultipleMyeloma studies at the European Hematology Association (EHA)’s Congress in Madrid this weekend. Attending the meeting? Click for details on our oral and four poster presentations: https://bit.ly/3R3DeaO #EHA2024 #CellTherapy
To view or add a comment, sign in
-
We are #hiring! Our growing global team aims to transform the #CellTherapy landscape in hematology and oncology. Meet our colleagues in Belgium and hear how their passion for patients is driving our transformational science. Interested in working alongside LEGENDary teams? Find open roles across our offices at https://lnkd.in/e-rXFgQq. #Biotech #JoinOurTeam
To view or add a comment, sign in
-
Our Head of Manufacturing Sciences & Technology (MS&T), Pieter Jacobs, was part of an esteemed panel organized by EP PerMed - the European Partnership for Personalised Medicine that brainstormed ways to expedite the production of personalized medicines. The roundtable focused on the immediate need to attract top talent and support ingenuity that drives advances in technology and manufacturing. Legend Biotech is proud to be leading the development of cell therapy technology in Europe. #EPPerMed #PersonalisedMedicine #CellTherapy #CART
To view or add a comment, sign in
-
Zaakvoerder TaLe Art Gallery- Contemporary Art
18hEmilia Gautot